Compound Reference

SLU-PP-332 + Orforglipron

An 'exercise-mimetic' + oral GLP-1 stack

Peptide blendEvidence: mixed (components)RUO + investigational (components)

Research Use Only. Not an approved medicine and not for human use. Educational only — no dosing or medical advice.

What it is

A stack of SLU-PP-332 (preclinical ERRα agonist) and orforglipron (investigational oral GLP-1 agonist). The two have very different evidence levels.

Proposed mechanism

Combines an oxidative-metabolism agonist with GLP-1 appetite/glucose effects; only orforglipron has human data, and the combination is not studied.¹

State of the evidence

SLU-PP-332 preclinical; orforglipron in Phase 3; combination unstudied.

Regulatory & status

Not approved; components RUO/investigational.

References

Oral GLP-1 agonists (literature). PubMed: orforglipron

Explore the full library & 75-compound reference →

For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.